Search Results 671-680 of 14816 for anti-TNF drugs

1. Polymyxin B And Trimethoprim (Ophthalmic Route) Before Using - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

2. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   Anti-CTLA-4 therapies: Patients who have received prior treatment with anti ... medications: treatment with systemic immunosuppressive medications ... TNF] agents) ...

3. Peripheral nerve tumors - Diagnosis and treatment - Mayo Clinic

   Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

4. Zonisamide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Radiation Therapy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to determine whether, in men with post-prostatectomy PSA recurrences, salvage radiation therapy (SRT) with enhanced anti-androgen ...

6. Butalbital, Acetaminophen, And Caffeine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Fenofibric Acid (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Fibricor; Trilipix. Descriptions. Fenofibric acid is used ...

8. Acyclovir (Topical Route) Description and Brand Names - Mayo Clinic

   Acyclovir belongs to the family of medicines called antivirals. Antivirals are used to treat infections caused by viruses. Usually they work for only one kind ...

9. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

   Being treated with anti-TNF therapies or has been treated with an anti-TNF therapy within 5 half-lives of randomization. Participating Mayo Clinic locations.

10. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...